Advanced Search

Gastroenterology & Hepatology Evaluations

To view Evaluated Articles, you must have an active subscription (or trial) and be signed in.
If you have an active subscription (or trial), please sign in. If your access has expired, you can subscribe at $9.95 per month. If you think you should be able to access this content, please contact us.

Sign in | Free Trial | Subscribe | Recommend to Library

New to F1000? See the Top Rated article below for a free preview of one of our Evaluated Articles.

HEADS OF FACULTY

  • Photo of Michael Farthing

    Michael Farthing

    St. George's Hospital Medical School , University of London, London, UK

  • Photo of Mario Strazzabosco

    Mario Strazzabosco

    Department of Internal Medicine , Yale University, New Haven, CT , USA

TOP RATED ARTICLE THIS WEEK [FREE TO VIEW]

12
Acetylcysteine for prevention of renal outcomes in patients undergoing coronary and peripheral vascular angiography: main results from the randomized Acetylcysteine for Contrast-induced nephropathy Trial (ACT).

ACT investigators. Circulation. 2011 Sep 13; 124:1250-9

2 Evaluations, most recent by

David Kluth and Neeraj Dhaun, University of Edinburgh, UK. F1000 Nephrology

Past 7 Days

31

New Evaluations

6,195 total

19

New Articles Evaluated

3,026 total

Past 30 Days

INDIVIDUALS

Get instant access to evaluations from over 10,000 experts in biology and medicine by taking a free trial or an individual subscription.

Get a FREE Trial Subscribe for $9.95 per month

Already have a subscription? Sign in for instant access. If you are signed in but are not able to view content, your access has expired. Please take out a subscription or recommend F1000 to your librarian.

RECOMMENDATIONS

Send a recommendation to your institution's librarian or information manager to request an extended free trial for all users.

Recommend to your Librarian

LIBRARIANS & INFORMATION MANAGERS

Get an extended free trial supporting clinicians and researchers at your academic or corporate institution.

Request an Institutional Trial

FREE ACCESS

Your institution might be eligible for free access via our sponsorship scheme. Check our sponsorship page.